What's more extreme to me is people like NRK's economy commentator Cecilie Langum Becker, who I read today went over to a lucrative job as communication chief in Aker. A corporate PR person by trade, for 8 years, she had front page space every day to push austeritarian, interest-scold propaganda that would make The Economist blush. So good of our public broadcaster to promote voices we rarely hear from in the media /s.
Actual grass roots organizations, even for unsympathetic causes like anti-pride, worry me less than the whole Orkla-Schibsted consensus.
Either way, I think the focus should be on the "respectable" corruption, not on unhinged noisy attention seeking outsiders.
Sometimes the expert benefits just by being in the news, see for example NPR banning the expert they quoted 77 times, law professor Carl Tobias. Mainly because he'd write to them offering his opinion on the topics of the day, and as he is a law professor, even if the topic isn't law, NPR journalists couldn't help but accept his quotes to pad out their articles. https://www.mediaite.com/media/nprs-new-rule-for-2026-stop-q...
Doctors commonly have kickback arrangements to prescribe specific medication. Sometimes it's the correct course of action they just always go for the particular brand, other times it's the wrong course of action but they prescribe it anyway for the kickback (the OxyContin scandal comes to mind).
This is a separate issue for media reporting on (say) new tanning treatments that are endorsed on screen during traditional "news hours" in undeclared infomercial segments that feature "independant" medical experts gushing over benefits of perineum UV treatments.
Frequently both the company that paid for the faux news segment and the guest experts that also benefit fail to have fiscal interests disclosed.
Doctors prescribing drugs recommended to them by pharma reps should disclose that connection.
On a media "news" program:
Producers of media programs should disclose any connection "experts" they interview on a subject have to the financial returns or funding of that subject.